位置:首页 > 蛋白库 > AGIA_ASPFN
AGIA_ASPFN
ID   AGIA_ASPFN              Reviewed;        7763 AA.
AC   B8NY88;
DT   11-DEC-2019, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 1.
DT   03-AUG-2022, entry version 77.
DE   RecName: Full=Nonribosomal peptide synthase agiA {ECO:0000303|PubMed:31117395};
DE            Short=NRPS agiA {ECO:0000303|PubMed:31117395};
DE   AltName: Full=Aspergillicins biosynthesis cluster protein A {ECO:0000303|PubMed:31117395};
DE   Includes:
DE     RecName: Full=Nonribosomal peptide synthetase {ECO:0000303|PubMed:31117395};
DE              EC=6.1.2.- {ECO:0000269|PubMed:31117395};
DE   Includes:
DE     RecName: Full=S-adenosyl-L-methionine-dependent N-methyltransferase {ECO:0000303|PubMed:31117395};
DE              EC=2.1.1.- {ECO:0000269|PubMed:31117395};
GN   Name=agiA {ECO:0000303|PubMed:31117395}; ORFNames=AFLA_010580;
OS   Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357
OS   / JCM 12722 / SRRC 167).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC   Aspergillus subgen. Circumdati.
OX   NCBI_TaxID=332952;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC
RC   167;
RX   PubMed=25883274; DOI=10.1128/genomea.00168-15;
RA   Nierman W.C., Yu J., Fedorova-Abrams N.D., Losada L., Cleveland T.E.,
RA   Bhatnagar D., Bennett J.W., Dean R., Payne G.A.;
RT   "Genome sequence of Aspergillus flavus NRRL 3357, a strain that causes
RT   aflatoxin contamination of food and feed.";
RL   Genome Announc. 3:E0016815-E0016815(2015).
RN   [2]
RP   BIOTECHNOLOGY.
RX   PubMed=26273902; DOI=10.1021/acs.jnatprod.5b00286;
RA   Kikuchi H., Hoshikawa T., Fujimura S., Sakata N., Kurata S., Katou Y.,
RA   Oshima Y.;
RT   "Isolation of a Cyclic Depsipetide, Aspergillicin F, and Synthesis of
RT   Aspergillicins with Innate Immune-Modulating Activity.";
RL   J. Nat. Prod. 78:1949-1956(2015).
RN   [3]
RP   FUNCTION, DISRUPTION PHENOTYPE, CATALYTIC ACTIVITY, AND INDUCTION.
RX   PubMed=31117395; DOI=10.1021/acschembio.9b00161;
RA   Greco C., Pfannenstiel B.T., Liu J.C., Keller N.P.;
RT   "Depsipeptide Aspergillicins Revealed by Chromatin Reader Protein
RT   Deletion.";
RL   ACS Chem. Biol. 14:1121-1128(2019).
CC   -!- FUNCTION: Nonribosomal peptide synthase; part of the gene cluster that
CC       mediates the biosynthesis of the aspergillicins A and F, 2 cryptic
CC       cyclic hexa-depsipeptides (PubMed:31117395). The hexamodular NRPS agiA
CC       catalyzes the condensation of the six amino acid residues including N-
CC       Me-L-O-Me-tyrosine, L-proline 1, L-proline 2, D-isoleucine, O-acetyl-
CC       threonine, and L-isoleucine (PubMed:31117395). The starting
CC       condensation domain (C1) of agiA probably loads acetyl-CoA which is
CC       condensed on the N-terminus of threonine by the first module to yield
CC       O-acetyl-threonine (PubMed:26273902). The second module then loads L-
CC       isoleucine. The epimerase (E) domain on module 2 is probably involved
CC       in the formation of the D-isoleucine moiety (PubMed:26273902). Modules
CC       3 and 4 further load 2 successive L-prolines (PubMed:26273902). Module
CC       5 is then involved in the condensation of O-Me-L-tyrosine produced by
CC       the O-methyltransferase agiB and the N-methyl transferase (NMeT) domain
CC       on module 5 probably catalyzes the N-methylation to yield the N-Me-L-O-
CC       Me-tyrosine moiety (PubMed:26273902). The A domain of module 5 loads
CC       preferentially O-Me-L-tyrosine, but it can also accept L-phenylalanine,
CC       which leads to the production of aspergillicin G (PubMed:26273902).
CC       Module 6 then loads the last residue, L-isoleucine (PubMed:26273902).
CC       The C-terminal thiolesterase (TE) domain probably cyclizes the peptide
CC       using the hydroxy group from threonine to form the cyclic depsipeptide
CC       (PubMed:26273902). {ECO:0000269|PubMed:26273902,
CC       ECO:0000269|PubMed:31117395}.
CC   -!- DOMAIN: NRP synthetases are composed of discrete domains (adenylation
CC       (A), thiolation (T) or peptidyl carrier protein (PCP) and condensation
CC       (C) domains) which when grouped together are referred to as a single
CC       module. Each module is responsible for the recognition (via the A
CC       domain) and incorporation of a single amino acid into the growing
CC       peptide product. Thus, an NRP synthetase is generally composed of one
CC       or more modules and can terminate in a thioesterase domain (TE) that
CC       releases the newly synthesized peptide from the enzyme. Occasionally,
CC       additional domains such as epimerase (E) or methyltransferase (MeT)
CC       required for further modifications are also present. Aspergillicins
CC       synthetase has the C1-A1-T1-C2-A2-T2-E-C3-A3-T3-C4-A4-T4-C5-A5-T5-NMeT-
CC       C6-A6-T6-TE domain organization. The epimerase (E) domain on module 2
CC       is probably involved in the formation of the D-isoleucine moiety and
CC       the N-methyl transferase (NMeT) domain on module 5 catalyzes the N-
CC       methylation of phenylalanine/tyrosine. The C-terminal thiolesterase
CC       (TE) domain probably cyclizes the peptide when releasing the final
CC       product from the enzyme. {ECO:0000305|PubMed:31117395}.
CC   -!- DISRUPTION PHENOTYPE: Impairs the production of aspergillicins A and F.
CC       {ECO:0000269|PubMed:31117395}.
CC   -!- BIOTECHNOLOGY: Aspergillicins show innate immunity-modulating activity.
CC       Innate immunity is a good pharmaceutical target for the development of
CC       immune regulators to suppress unwanted immune responses, such as septic
CC       shock, inflammatory diseases, and autoimmune diseases. The innate
CC       immune system also provides targets for the development of agents that
CC       stimulate protective immune responses toward some diseases, such as
CC       infections with pathogenic organisms and cancer.
CC       {ECO:0000269|PubMed:31117395}.
CC   -!- SIMILARITY: Belongs to the NRP synthetase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EQ963486; EED45174.1; -; Genomic_DNA.
DR   RefSeq; XP_002385303.1; XM_002385262.1.
DR   SMR; B8NY88; -.
DR   STRING; 5059.CADAFLAP00013168; -.
DR   EnsemblFungi; EED45174; EED45174; AFLA_010580.
DR   VEuPathDB; FungiDB:AFLA_010580; -.
DR   eggNOG; KOG1176; Eukaryota.
DR   eggNOG; KOG1178; Eukaryota.
DR   eggNOG; KOG1256; Eukaryota.
DR   HOGENOM; CLU_000033_0_0_1; -.
DR   OMA; WEPVPSV; -.
DR   Proteomes; UP000001875; Unassembled WGS sequence.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0043604; P:amide biosynthetic process; IEA:UniProt.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   GO; GO:1901566; P:organonitrogen compound biosynthetic process; IEA:UniProt.
DR   Gene3D; 1.10.1200.10; -; 5.
DR   Gene3D; 3.30.300.30; -; 7.
DR   Gene3D; 3.30.559.10; -; 7.
DR   Gene3D; 3.40.50.12780; -; 5.
DR   Gene3D; 3.40.50.150; -; 1.
DR   Gene3D; 3.40.50.1820; -; 2.
DR   InterPro; IPR010071; AA_adenyl_domain.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   InterPro; IPR001031; Thioesterase.
DR   Pfam; PF00501; AMP-binding; 6.
DR   Pfam; PF13193; AMP-binding_C; 3.
DR   Pfam; PF00668; Condensation; 7.
DR   Pfam; PF00550; PP-binding; 6.
DR   Pfam; PF00975; Thioesterase; 1.
DR   SMART; SM00823; PKS_PP; 4.
DR   SUPFAM; SSF47336; SSF47336; 6.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   TIGRFAMs; TIGR01733; AA-adenyl-dom; 6.
DR   PROSITE; PS00455; AMP_BINDING; 6.
DR   PROSITE; PS50075; CARRIER; 6.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 3.
PE   1: Evidence at protein level;
KW   Isomerase; Ligase; Methyltransferase; Multifunctional enzyme;
KW   Phosphopantetheine; Phosphoprotein; Repeat; Transferase.
FT   CHAIN           1..7763
FT                   /note="Nonribosomal peptide synthase agiA"
FT                   /id="PRO_0000448728"
FT   DOMAIN          995..1071
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          2090..2166
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          3667..3743
FT                   /note="Carrier 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          4806..4880
FT                   /note="Carrier 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          6306..6381
FT                   /note="Carrier 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          7446..7522
FT                   /note="Carrier 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   REGION          20..168
FT                   /note="Condensation 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          469..866
FT                   /note="Adenylation 1"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          1104..1526
FT                   /note="Condensation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          1562..1968
FT                   /note="Adenylation 2"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          2212..2556
FT                   /note="Epimerase (E)"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          2676..3016
FT                   /note="Condensation 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          3136..3531
FT                   /note="Adenylation 3"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          3789..4238
FT                   /note="Condensation 4"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          4321..4687
FT                   /note="Adenylation 4"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          4902..5339
FT                   /note="Condensation 5"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          5361..5765
FT                   /note="Adenylation 5"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          5820..5975
FT                   /note="S-adenosyl-L-methionine-dependent N-
FT                   methyltransferase"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          6378..6399
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          6424..6883
FT                   /note="Condensation 6"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          6913..7327
FT                   /note="Adenylation 6"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   REGION          7542..7638
FT                   /note="Thioesterase (TE)"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:31117395"
FT   COMPBIAS        6378..6397
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1032
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         2127
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         3704
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         4840
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         6341
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         7483
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   7763 AA;  858957 MW;  B9F2EBD7DDF09788 CRC64;
     MGSIGNVQSP LPRCVQSMHA PSVMQEEMIV STIADPSHKS YFETYHFSAQ GIVDPDQLNG
     AIHAVARKHA VLRSVFVHPT EFDSTNVQIA VLDQAYTLHR AKLLSLQPIG EEIRFGILPL
     ESIGTDEWDG VMPWKFSLVV CEREQKSYIT VRYHHALLDG WSARALLELV QQEMLNPGAV
     LKGSDFFSLV RQPLKRDWKQ DETLLRERLA QIETSPILSP GPVANGDLRV GEVTREVSIS
     SDIWLPDRPA VPARLLRLAL GMTISVFRNS DDSLFLEITS ARSRLFPKDQ QVLGPVLAPQ
     VRNIHLKEHT TLGECMQLLR SSNDPQHNFS VSQLKSFLTE SSRDLDVCLV CQTNESYPSN
     GVGHWEWIKG EARNDLPFIL EILPPKEGVF FAKIRYHQNR FEKQFADSFL EFFCQTLTWM
     QATGNSIDHQ TFAAAVSEIC RQGDYRQHYL ALNPRGVSDD PVNVHDLIEQ AASKWPSKIA
     LEAEHNQFMT YAELSNESDR VAKGLRHCLP RDQKDQPLVP ICFDKSVDMV VAIVAVLKAG
     GAYVPLDPSQ PRDRLVSILS ACHATVVIAG QTDLQDVLHS TCSELSILVT SIENLSEHDK
     STDELSGSEH PPPSSLAYVL FTSGSTGTPK GVMVEHRNLV AFMKAGEGNA DGTWTSTRLQ
     LAAYSFDASI GDIFANLYRG GRLALVQRNK MLSNLNHWLE EMLITHLALT PTIGDLIISH
     LPPRLQTLMF GGEPFHQSFL AQAPAEARVW NTCGPTETVV DVACCILQKE NPDVPIGRPF
     GQCQIYILRR GGSNTAVPPN AIGEICVAGP QVSRGYLERP DLTSLGFVTD PFRPSQRMYR
     TGDLGRLNHR GMLEHLGRAD GQIKLRGLRV ETGEVEVTIK QSSSIIAQVT VSVNHLEGYD
     REALVAWIVP EASQGSQDIE LAWQEDIMPS CQRRLVPYMI PEVWIMISYL PLTVSGKLNR
     GTLASWVEHV ATGGTHDGLY VITAPWKTQE ITQRLPESPA ERLLVATCAN ILGTTLHAVS
     MDSTFIALGG NSLLAMRLLA ALRQEGMNCS LRDLLTPMTL GDVARAMSPS STPKKQITKA
     FYHEDSWERI VADSSIAADT IDAIYPCTPQ QEGLIQTSLH GDKSAYFATI TVHLGDSLNL
     RTFHAAWNRL VFGCDMLRTA FVSFSEVQHP PVSESNILQV VLSQSAEDVR RLVSLDNRDI
     AFQFGVVPLS AGISQGSVNE PWRLHLKIHH ALYDEAFLSR IVAELCIVYE ALEMESSEAA
     LPPSRPFSAF VESLCNDDPE VSKGFWKKYM HEVAPATWPV ASGIRRMREE NGQDVEMTVV
     KSWTGNAVAL GQKFQATPAS IVRAALALAL AQYSQTDDVV FGEVSSGRFD HDRFTLGPCL
     ATHPVRIQID RKSSSGMLKL VTQALESYLA TTPYQHCGLA SIHRQTADPD LMAFQVLFAH
     QEAFVEYTAG SRFHVKSAKL RNIGFPLVLE SRCDRSTGNL AFECSFDRRY LGDQDVDWFL
     RSICRTLDMF SAGARDGLSD QKLITGVVDE EMRRAIEKWS TKRTPFGSTF TRNAEICAHE
     LFEMQADMTP QKIALQVNQS EFITYKELNK RCNQLSNALV NWLDSLGLEQ SRDQQIVPLC
     FSNAVDMVIA MIAVLKAGAA YLPIDQNHPQ ERIQQILSLS GARAMLGDGE AETLEKLQAA
     SKQANSTLIT SKRLRTLYGG QTAKKPSFRP TPASLAYVIF TSGSTGKPKG VMVEHGNLAA
     FMQANEPEAV GTWTSVRLQL ATATFDAATG ETFGTLGCGG RLILGQTHEI LAGLPDWLER
     TNITHLFVTP RVAANFLTEI HPPYLRTLHI GGEAFDPSIL PHMPPGCDVY NVFGPTETTI
     YATHYKIRKG DGIRRNIPIG YPFGGCRLYI LNPETLEQVP IGVIGEICIG GPQVTRGYQG
     RPELTSRSFL SDPHIVGERM YRSGDLGRLC GDGSIEHHGR IDSQIKLRGL RIEISEIESV
     CLEHAIATAC TVIVLDREDG QVLVAFVQTQ KDQQTSTCSQ DWAETESILH RHLDSRLPSY
     MVPSRFVPIE VMPLTTSGKV DRRQLGARAE TMDQAGELFT SQHTNHAGSW EQGSIEDKIA
     DAWVQVLGID RANITPNVAF SRLGGDSIRA IRLLSLLRKA GLKLNMTDVS NASTIFSQAK
     CATSHTVAAK KSTEDATDID AHTGPVALGP IAGRYAGIQL KYASQRGEQI IDHFNQSVLL
     DVTTLCPLRL QQALQRLRNH HDPLRAIVHW SLDIPVEEWT IRILPCSDIK PLVLDSPRTL
     TLQALREQIQ HRITGLDIRR GKVMDAELYR LDGDSRVFLF WTVHHFVVDI VSWQILRDDL
     NVLVRAKEEP ESIALQPATM SFLAWTREGQ MKSQDASLAT GSIPEEPDIL LSSSDSDQLP
     LWVRQPELVP IHPVNRTTTS ASLSPCITAL LLGRSNNVLS TEPLDLLLAG LAMTISKHFA
     RAVDRLVVGL ETHGRHTGTN TADLSRSIGW FTAIIPMILD CRCESSSIES VVRRVKDQRR
     LLMENDRGFR HFVASRWSTA NARKSEIMPL VFNYQGVRHD PHDHDEMMLH PVQIPGLSWI
     ESSPHAIPLS HAAFELYVHD RQAYIEATWP SDGEMDQEDV ATLMGEQITN ICQYLAEKDV
     LGKTSISASS TSAFGLLPDD CFDRVFSLYP EDTLDDIIPC TPMQRALLYE GIADHESRSY
     VTCRIWRIPT DQAICSQIEG AVKSLIQRHG ILRTVFHIDP EVGPLALVLR DTQSPTASAV
     GHVKVKDHTE MEERVTSLLC NPDYGNPMKQ AFYVRIVHAA DGSGARLIWL LHHSLIDAWS
     QDLLLSELTQ ILVDGCPTKS LIPRPSFGSF ARYVTSDSRA DHSHGKFWSE TLNGVQPKSL
     PLSLMSSSPI NAAAVVVEQA CNLAILSENC ISPAALVSLA WSLVLSEILD TDDVTHGMLF
     SGRQLPVDGV ADIIGPCIST VPIRTHLNRH GKVLDLLQST EAAIRLAGSH STVGVDGVAR
     AAGVEAPALV NTLLNFFGVR TDVLENDGLN SILELDSVDD GLPPSITLSC WQREVDANIM
     VMRLERRHPL QIGIAQCLVK RMAWYCHTLS HHMDRKLDSV LSITSNEDQL LTKWSQPVDS
     RPSDSYPCIH DLITGWAAQV PEKVAVQVAE SQFVTYGEIE KKSTAIARVI ERLVDPRSGS
     TPPLIPICCD RGVDMVIAIL AILKAGAAYV PLNISDPEGR LEAILRQTGS TILVDGLLDK
     GSRRKLHALG DRTSTTVYTV DGLSILPPSE VSLRKAHSES LAYVLFTSGS TGEPKGVMIE
     HRNLTSFITT QHNEIIGRWT SCRMPVAAYT FDVSMADLLI SLAIGARVAL VDSEKMLASM
     PYWADRTLAT TLSMTPTLAS LLARSLPPHV AVLMLAGEVF DPNIMKALPR ECRVWNGYGP
     TETFYASFHP VDAQPTHAQV PIGRSFGGNR IYILRPGSNY RQPIGAIGEI CIGGTQVARG
     YLGREDLTSR SFTRDPYNTQ TVLYRTGDLG RFTDCGVVEY LGRMDDQIKI RGQRAEPAEI
     ESVVHAASPR VAHAIVDLYQ SKRGGGLPRL IAFISTKDPV PPSLCKTFLQ EEVEPSCRNQ
     LPGHMMPSTW IYVRTVPLTS SGKADKRMLR SWMARLEEGE TVPEASIIEL SLSTQMNSET
     HQDISGGPES PTEIMLRQSC AQLFKVNEDI ISLDKSFISS GGDSLLALQL NARLREKGLK
     CTPRDIVEAQ SLAELATILN TSYEAVSPVH MADWTLDLNE MARLPDNGIQ GWETIVQRVG
     IDPGQVRCVM PCTPFQEGVL SSNDESGSSA GYLAHMTVGL GKEIDVEALK YAWQETVDHE
     DMLRTTFIPA DMDMTDIRGL GQGSSLLQVV LYPESPQAGR VKTMKTVSTP ATPNAALPSY
     PSLQGKAQQG HIPVAALVAI GSQDGEGQEC TLLITMHHAL YDEAYLSLLL KDLSGRYRSI
     ACNEVVPQVP EDQRIPFSTY VRFVHSKLGT APSTSTAGKF WKSYLADATP STWPLPHGMQ
     SSITSVKSPE TAVLEWTGNL RAAASKVQVT AAAIARAALA LTVAEHTNVT DVVLGEVSKG
     RPDIRGPGDA RARFITGPCA TTHPVRIRIA DEGASKRRTM LQLLRESFTS YMETLPHQFY
     GLSRIREQSC RVDLLPFQVL FVYQDAFRQK EGLAGDDAFQ IQGGNLGQMG FPIVLECSCL
     SGDSGVVFHC TYAPDVIDKP RIEWFLHHIS QSIDALVQVD PARSDSLRSA RVPLSAQETR
     QLELWSRCHA AKDVEKVDDT MPTETSSITH AFDDTARNLH EKRSTSLSMA LQRHIVSLDD
     VGSQQPIIPI CFERSTDMVV AILAILKAGA AFVPLEPGYP PERLISIVRT ARASLMICGK
     EDKSNEILVS VCHATNTKLI TLEDLKSRPA SSDQAVISRY CRDDSRIAYV LFTSGSTGTP
     KGVVITHRNL LAFMRHNNPD VHGRWYNSRM PVASYTFDVS MADIITTLCC GGRVVLVPVQ
     KLLPSLGAWV DASITSHISL TPTIANMLWE PVKNAEIAFP FLSVLLLAGE VFDAQLMSYV
     PKECRVWNGY GPTETFYVTF YRVPKAHAKE QTSVSIGYPF GENVIHLLGF ESNDHVPVGC
     IGEICVMGPQ VAQGYLGQPE LTKQRFKRGV ISQAPEGFLY RTGDIGRFHP DGKLEYLGRF
     DRQIKIRGQR VELAEIEMAI AQHSFVDGCA VVVVNTPTGD SLVGFCVKTS SQTPGKGWDA
     NTAVQIKTWI STRLPAHMVP SYLFPLEGEL PRVPSGKVDR QLLAQRATDL LADSLLSSQG
     QDTYIAPTTE REKVICEIFE ETLAQRVSVL DNFLHLGGHS ILAIRAVSKI NHRLHANLTF
     KDVFDFATAR DLARQLESTA TNHRSYTSIP RLTQDKMIVR QSFAQGRLWF LDQLHPGSTW
     YLMPFGLRIQ GDLHLDALEA AVSAIEERHE TLRTTFEHRD GENVQVVHPF AHRQLRVVEV
     PPAVDEEGLL GALKEEQSTP FDLQVHPGWR PLVLRQNKRS HILSIVIHHI ICDGWSVAVL
     LKELSTFYSA ALHGKPIHAQ LPPLPIQYRD FSAWESQKEQ RVEHDRQLKY WIEKLTGSKP
     AEFICDKRRP QAPSRQAIFE EVRIDGAMYD QLRQYCKQHQ LTPFIVLLAV FRATHYRLTR
     EADATIGTPI ANRGREELHD IIGLFVNVQC IRLKVDDHHT TFEDLVNQAQ STATEAFAHQ
     DIPFDRIVSA LQPDRETTQN PLVQTVFAVH PQTQGKEELE GLLTEQILLS RTTRFDLEFH
     LFQEEDGLSG QVVFAQDIFF PETVKAMISV FYAVLECGLN QPSISVASMA LLNDLSMHDM
     DDLLSINQTD YPRDATVVDL FRQEARSHPD SIAIVHEGKE VTYGELDRQS DNIERWLRSL
     HLDRETIVGV LAARSAEAIT VFLGIMKADL AYLPLDASTP QTRICSVLSC ISERITVIVV
     DGAQVAVPDV SLAHVDFVAL SNLLDDQRHK PSDNQKFESE SSISATSLAC VLFTSGSTGR
     PKGVMIEHRA IVRLAKDFNF AKAAGKPLAH MASLSFDVST WEVFMPLLSG GVVVCVDAMT
     VLDYKALSDV YARHHVRAAM FTPALFKQCL HDSPSIVKNL DLLILGGDRL DPEDVFQAKQ
     LTQGIILNGY GPTENTGAST IYPIPDEESC VNGVPIGKPI GNSGAYVMDD SLNVVPKGVV
     GELVVTGDGL ARGYTDPEKN EGRFVHVVIG QDTVRAYRTG DYARWRPIDG QLEYFGRRDD
     QVKIRGNRVE IGEIEHNILS HSAVRSAAVV MNGVGAEADL AAFVTLHPIH DDVAETERVD
     AWKNVFDTEA YDSFTHQPNR LGRDFVGWLS MYDGCNIDLT EMDEWLDDTL QTLLNGQDPG
     KVLEIGTGSG MILFNITKGL EEYVGIELVP KLAHMVEQVA NADQRLAGRV KVHPGVADRV
     EDFIPGFIPD LVIINSVAQY FPSAGYLSEI VQKLVRLQGV KSLFFGDIRS YPLYDEFLVS
     KALHNAGARA TQDQIRKCIE ESKAAETELL VDPAFFTSLT NQFPDQVAHV EILPKLMNAT
     NELSCYRFSA VVHLKHATAA TRIACQVKKA DWIDYTARSL NSRSLLEHLR SSHDNTIIAV
     ENIPNRRTIL ERYIVDALKE GVEPRSMDTK SHWQVRHRNR AAQSSALLPG DLVAIANQAG
     FQVEISWARQ SSQRGAFDAI FHRMGPNSRR QRVLFDFPVD HQCRDVDSFT NHPVQGQQDQ
     QCIFELKESL RAQLPAYMIP RTITILDQLP LTDRGKVDRQ ALRQRIIKQE PVATESESSA
     GRVTVEYGSE MERILCDVFA EVLGLQSVDR ESSFFSLGGH SLLAPRLASR VSKRLDCTAT
     VRDLFDCPTP VRLADRLLSK QSDSNTEANT STDGKTQHSA LDKVKYHNTL RDWGVQSSEV
     GHLMPCTPFQ EGVLSNSLAV PGDSGYLSVV RLGLQSQLDT KAMRLAWQKV VEREETLRTA
     FIPVAEDLSS ACITSSTFWQ CIFNINSREV QRLLCIEGRN SGVDRSALGF GHIPVSLILT
     DVPTVCKARG VGSTQLELTI HHALYDEAYF RWIIHELSRE YHKARLAKDY VPLRAPQTSM
     NRIPFSIFVS QLQAMPKESA TSFWKSYLNG APAACWPVAR GLESGRITEI DEFSSRSLIW
     KGNMHNLAGA RGVTPAAISR AAVALVVAEH SGVEDIVLGE VSSGRSITDG AAGFVAGPCI
     STHPIRIRMQ QRQGSRSSQH RLSFDQLVKQ SLNSYLETVP YHQLGLPSIR RQSDAPDLLP
     FQVLFVYQQA FDFETDSREE ASHNFKVQGG HLGRFEFPVV LQASCHPVTG HMSLQCMFDP
     TVLITEDIEW FLEHISQVLS SIADSSSQPV ARLTVGDAEE AALTKLSCAK DQTPELPLGT
     DSESLCAHDL ISRQAMESPC KIAVQYELSQ FMTYGELDRE STKLSIVIRA FFDHLSKSVS
     HEQPLVPISF DKGLDMIVTM LAVLKAGAAY IPLDISHSEQ RLRMICQSAQ AKLILWDGQN
     GFDKLRAIGH SSGATISTVD ELSDAVDGWG STPRSGEKPN LSSLAYIIYT SGSTGVPKGV
     MVNHANLVSF MRSATNETYM SWTANRLQIA SYAFDMSVSD IFPVLAVGGR VLLARQQSLW
     SDLAGWVDAF AVNQLMTTPT VADMMLSSAL SDGFLLAHLR DVIVGGEAVK RDILDKAPTE
     MVFWIQYGPT ETTVVVTGCM FRGPTYYQPV PHSQITTIGF PLRGCRVYIL QPGTSNRVPI
     GVPGELCISG PQVTMGYRGG GDPSESPFVP DPFWAGQTMY RSRDIAKVHG DGMIEWVGRM
     DSQVKLRGLR IDLGEIESAA RQLNGVQSCA VVKLALEDKE TLLAFIEVAK SHQTHITPVT
     IQQHIAQNVP SYMVPAHLRL LDKPLPRTAS DKLDRKGIHA LAQQLVDNGD LLSSCTSRIP
     PADLRPSPGT LEATLASYWG TILGIDQEVI SLETPFSHLG GDSVRAISLL ALLRRNNFQL
     NLTDLGSFST IRSQAFRILC DVQPQKLPAY MQLTTRSTSR ATMVLIHPFF GQSSVFDHVV
     PALSEQYDIV QVSDPFFGKP DGPASLRDWA AHYLEALHVH LEQDRPVVLV GYSFGGLLVL
     EMARLLEMTG KGSPFSTVIV DTRCYDPDQP FFKDEEERQT AADDAVRLFG PGQTSMIEEH
     FDKHAHIWEN SVCPDKYLGR SLYLATPEAV ESGIVDWWRN QCPHIEVQRV ECSHGEIFEP
     AMTGRVSALI NGHCDLDFTR IEP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024